n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Celiac Disease in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Celiac Disease: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mazzarella, G | 1 |
Bergamo, P | 1 |
Maurano, F | 1 |
Luongo, D | 1 |
Rotondi Aufiero, V | 1 |
Bozzella, G | 1 |
Palmieri, G | 1 |
Troncone, R | 1 |
Auricchio, S | 1 |
David, C | 1 |
Rossi, M | 1 |
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Celiac Disease
Article | Year |
---|---|
Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice.
Topics: Animals; Apoptosis; Caspase 3; Celiac Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diseas | 2014 |